Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AROW | Common Stock | Options Exercise | $32.8K | +1.16K | +2.63% | $28.29 | 45.3K | Feb 17, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AROW | Director Stock Option (Right to Buy) | Options Exercise | $0 | -1.16K | -100% | $0.00* | 0 | Feb 17, 2023 | Common Stock | 1.16K | $28.29 | Direct | F2 |
Id | Content |
---|---|
F1 | The information provided reflects 16 shares acquired under the Company's DRIP since February 01, 2023 which were not required to be reported on a Form 4. This information is being furnished to disclose the total holdings of the insider as of the date of this Form 4. |
F2 | The options vest in four equal installments beginning January 31, 2019 |